The effects of treatment with the gap junction enhancer PQ1 reduced proliferation and viability, while also inducing an upregulation in Cx43 expression in an epithelial based mammary carcinoma cell culture derived from a malignant murine tumor. This evidence concerns the gene GJA1 and neoplasm.